Track the 지투지바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지투지바이오 has recorded 24 reports. Market capitalisation: €500.5bn. The latest transaction was reported on 22 May 2026 (Purchase). Among the most active insiders: 이희용. All data is free.
24
Insider Decl.
n/a
Thresholds
€126,583
24 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €126,583n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
지투지바이오 es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biofarmacéuticas.
